---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-086339"
form_type: "8-K"
ticker: "SEM"
cik: "0001320414"
company_name: "SELECT MEDICAL HOLDINGS CORP"
filed_at: "2023-08-01T23:59:59+00:00"
generated_at: "2026-06-12T17:16:58.796652+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Select Medical refinances $2.8B credit facilities, extends maturity to 2027

## Summary
- New $2,103.0M tranche of refinancing term loans replaces existing term loans.
- New $710.0M revolving credit facility replaces existing revolver.
- Maturity extended to March 6, 2027; springing maturity if >$300M senior notes outstanding.
- $60M incremental revolving commitment from Mizuho Bank added on July 31, 2023.
- Upfront fees: 0.15% on extended revolver, 0.50% on term loan conversion, 0.30% on incremental revolver.

## SEC filing metadata
- accession: 0001104659-23-086339
- form_type: 8-K
- ticker: SEM
- cik: 0001320414
- company_name: SELECT MEDICAL HOLDINGS CORP
- filed_at: 2023-08-01T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1320414/000110465923086339/0001104659-23-086339-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1320414/000110465923086339/tm2322495d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-086339
- JSON: https://secwatch.observer/filing/0001104659-23-086339.json
- Plain text: https://secwatch.observer/filing/0001104659-23-086339.txt

## Key facts
- Material Agreements
  SELECT MEDICAL HOLDINGS CORP amended Amendment No. 8 to the Select Credit Agreement with Select Medical Corporation, Select Medical Holdings Corporation, and JPMorgan Chase Bank, N.A. as administrative agent valued at New tranche of refinancing term loans of $2,103.0 million, replacement revolving credit facility of (effective 2023-07-31).
  - Action: amendment
  - Agreement: credit facility
  - Counterparty: Select Medical Corporation, Select Medical Holdings Corporation, and JPMorgan Chase Bank, N.A. as administrative agent
  - Value: New tranche of refinancing term loans of $2,103.0 million, replacement revolving credit facility of
  - Effective: 2023-07-31
  source text: On July 31, 2023, Select Medical Corporation (“ Select ”) and Select Medical Holdings Corporation (“ Holdings ”) entered into Amendment No. 8 (the “ Select Amendment ”) to that certain Credit Agreement, dated as of March 6, 2017, by and among Holdings, Select, the lenders and issuing banks party thereto from time to time and JPMorgan Chase Bank, N.A. (“ JPMorgan ”), as administrative agent and collateral agent (as amended by Amendment No. 1, dated as of March 22, 2018, Amendment No. 2 dated as of October 26, 2018, Amendment No. 3, dated as of August 1, 2019, Amendment No. 4, dated as of December 10, 2019, Amendment No. 5, dated as of June 2, 2021, Amendment No. 6, dated as of February 21, 2023, Amendment No. 7, dated as of May 31, 2023, and the Select Amendment, the “ Select Credit Agreement ”). Among other things, the Select Amendment (i) provides for a new tranche of refinancing term loans in an aggregate principal amount of $2,103.0 million to replace the existing tranche of term lo
  evidence_url: https://www.sec.gov/Archives/edgar/data/1320414/000110465923086339/0001104659-23-086339-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.